[1] FERLAY J,SOERJOMATARAM I.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359-386.
[2] MIRAVITLLES M,SOLER-CATALUNA J J,CALLE M,et al.Spanish COPD guidelines(GesEPOC):pharmacological treatment of stable COPD Spanish society of pulmonology and thoracic surgery[J].Arch Bronconeumol,2012,48(7):247-257.
[3] BAUER C M,MORISSETTE M C,MPFLIMR S T.The influence of cigarette smoking on viral infections:translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically[J].Chest,2013,143(1):196-206.
[4] 任成山,白莉,钱桂生.慢性阻塞性肺疾病合并肺癌临床特征及新理念[J].中华肺部疾病杂志,2015(2):137-142.
[5] SCHWARTZ A G,RUCKDESCHEL J C.Familial lung cancer:genetic susceptibility and relationship to chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2006,173:16-22.
[6] YANG P,SUN Z,KROWKA M J,et al.α1-antitrypsin deficiency carriers,tobacco smoke,chronic obstructive pulmonary disease,and lung cancer risk[J].Arch Intern Med,2008,168:1097-1103.
[7] HOSGOOD H D,CAWTHON R,HE X,et al.Genetic variation in telomere maintenance genes,telomere length,and lung cancer susceptibility[J].Lung Cancer(Amsterdam,Netherlands),2009,66(2):157-161.
[8] SAVALE L,CHAOUAT A,BASTUJI-GARIN S,et al.Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease[J].Am J Resp Crit Care,2009,179(7):566-571.
[9] PILLAI S G,KONG X,EDWARDS L D,et al.Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2010,182:1498-1505.
[10] YOUNG R P,WHITTINGTON C F,HOPKINS R J,et al.Chromosome 4q31 locus in COPD is also associated with lung cancer[J].Eur Respir J,2010,36(6):1375-1382.
[11] CHO M H,BOUTAOUI N,KLANDERMAN B J,et al.Variants in FAM13A are associated with chronic obstructive pulmonary disease[J].Nat Genet,2010,42(3):200-202.
[12] YOUNG P,HOPKINS R J,GAMBLE G D,et al.Genetic evidence linking lung cancer and COPD:a new perspective[J].Appl Clin Genet,2011(4):99-111.
[13] DURHAM A L.The relationship between COPD and lung cancer[J].Lung Cancer(Amsterdam,Netherlands),2015,90(2):121-127.
[14] TESSEMA M,YINGLING C M,PICCHI M A,et al.Epigenetic repression of CCDC37 and MAP1B links chronic obstructive pulmonarydisease to lung cancer[J].J Thorac Oncol,2015(10):1181-1188.
[15] SCHETTER A J,HEEGAARD N H.Inflammation and cancer:interweaving microRNA,free radical,cytokine and p53 pathways[J].Carcinogenesis,2010,31(1):37-49.
[16] ROOS A B,SANDEN C,MOI M,et al.IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis[J].Am J Respir Crit Care Med,2015,191(11):1232-1241.
[17] YANG B,KANG B,FUNG A,et al.The role of interleukin 17 in tumour proliferation,angiogenesis,and metastasis[J].Mediators Inflamm,2014,2014(4):623759.
[18] NEURATH M F.The emerging role of T cell cytokines in non-small cell lung cancer[J].Cytokine Growth F R,2012,23(6):315-322.
[19] CURTIS J L,FREEMAN C M.The immunopathogenesis of chronic obstructive pulmonary disease:insights from recent research[J].Proc Am Thorac Soc,2007,4(7):512-521.
[20] 陈怡,邓宏伟.慢性阻塞性肺疾病合并支气管肺癌的临床诊断研究[J].中国实用医药,2015(10):25-26.
[21] MACKINNON A C,KOPATZ J.The molecular and cellular biology of lung cancer:identifying novel therapeutic strategies[J].Brit Med Bull,2010,95:47-61.
[22] MANNINO D M,AGUAYO S M,PETTY T L.Low lung function and incident lung cancer in the United States:data from the First National Health and Nutrition Examination Survey follow-up[J].Arch Intern Med,2003,163(12):1475-1480.
[23] WILLE M M,DIRKSEN A,ASHRAF H,et al.Results of the randomized danish lung cancer screening trial with focus on high-risk profiling[J].Am J Respir Crit Care Med,2016,193:542-551.
[24] LOWRY K P,GAZELLE G S,GILMORE M E,et al.Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease:a decision analysis[J].Cancer,2015,121(10):1556-1562.
[25] SANCHEZ-SALCEDO P,WILSON D O,DE-TORRES J P,et al.Improving selection criteria for lung cancer screening.The potential role of emphysema[J].Am J Respir Crit Care Med,2015,191:924-931.
[26] HASHIMOTO N,MATSUZAKI A,OKADA Y,et al.Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients[J].BMC Pulm Med,2014,14(1):14-20.
[27] PALMA D,LAGERWAARD F,RODRIGUES G,et al.Curative treatment of stage Ⅰ non-small-cell lung cancer in patients with severe COPD:stereotactic radiotherapy outcomes and systematic review[J].Int J Radiat Oncol,2012,82:1149-1156.
[28] KIRI V A,FABBRI L M,DAVIS K J.Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking[J].Resp Med,2009,103(1):85-90.
[29] PARIMON T,CHIEN J W,BRYSON C L,et al.Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2007,175:712-719.
[30] YOUNG R P,HOPKINS R.Pharmacological actions of statins:potential utility in COPD[J].Eur Respir Rev,2009,18(114):222-232.
[31] NOHRIA A,PRSIC A,LIU P Y,et al.Statins inhibit Rho kinase activity in patients with atherosclerosis[J].Atherosclerosis,2009,205(2):517-521.
[32] LIU J C,YANG T Y,HSU Y P,et al.Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients:a population-based cohort study[J].Oncotarget,2016,7(37):59618-59629.
[33] ZHAI R,YU X,SHAFER A,et al.The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection[J].Chest,2014,145(2):346-353.
[34] 夏俊,于在诚,聂弘,等.合并慢性阻塞性肺疾病对老年肺癌患者术后并发症及预后的影响[J].中国老年学杂志,2015(11):3066-3067.
[35] IZQUIERDO J L,RESANO P,EL H A,et al.Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors[J].Int J Chronic Obstr,2014(9):1053-1058.
[36] DE-TORRES J P,MARIN J M,CASANOVA C,et al.Identification of COPD patients at high risk for lung cancer mortality using the COPD-LUCSS-DLCO[J].Chest,2016,149(4):936-942. |
